PRMEPrime Medicine, Inc.
$3.58-39% 1Y
$3.58
$2.7052 weeks$6.45
Is the price fair?
What PRME's price assumes
Prime Medicine, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 156× revenue.
156
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 8.19
Price / book · as of 2026-Q1
- EV / sales
- 168
EV / sales
Details›
- Price / bookas of 2026-Q1
- 8.19
- EV / salesas of 2026-Q1
- 168
- Market capitalisation
- $647M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.